Thanatin activity on multidrug resistant clinical isolates of Enterobacter aerogenes and Klebsiella pneumoniae

International Journal of Antimicrobial Agents

Volumn 22, Issue 3, 2003, Pages 265-269

  Pagès, Jean Marie ^a   Dimarcq, Jean Luc ^c   Quenin, Solange ^a   Hetru, Charles ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c Entomed SA   (France)

Author keywords

Antibiotic transport; Antimicrobial peptide; Efflux pump; Enterobacter aerogenes; Klebsiella pneumoniae; Multidrug resistance

Indexed keywords

ANTIINFECTIVE AGENT; CHLORAMPHENICOL; NORFLOXACIN; PORIN; TETRACYCLINE; THANATIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROBACTER AEROGENES; INSECT; KLEBSIELLA PNEUMONIAE; MEMBRANE PERMEABILITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0041833323     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00201-2     Document Type: Article

References (25)

1. George A.M. Multidrug resistance in enteric and other Gram-negative bacteria. FEMS.Microbiol. Lett. 139:1996;1-10.
2. Nikaido H. Multidrug efflux pumps of Gram-negative bacteria. J. Bacteriol. 178:1996;5853-5859.
3. Saier M.H. Jr, Paulsen I.T. Phylogeny of multidrug transporters. Semin. Cell Dev. Biol. 12:2001;205-213.
4. Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 12:2001;215-223.
5. Alekshun M.N., Levy S.B. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:1997;2067-2075.
6. Arpin C., Coze C., Rogues A.M., Gachie J.P., Bebear C., Quentin C. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J. Clin. Microbiol. 34:1996;2163-2169.
7. Davin-Regli A., Monnet D., Saux P., Bosi C., Charrel R., Barthelemy A., Bollet C. Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J. Clin. Microbiol. 34:1996;1474-1480.
8. Chollet R., Bollet C., Chevalier J., Malléa M., Pagès J.-M., Davin-Regli A. mar operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob. Agents Chemother. 46:2002;1093-1097.
9. Charrel R.N., Pagès J.-M., De Micco P., Malléa M. Prevalence of outer membrane porin alteration in β -lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob. Agents Chemother. 40:1996;2854-2858.
10. Malléa M., Chevalier J., Bornet C.E., Eyraud A., Davin-Regli A., Bollet C., Pagès J.-M. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology. 144:1998;3003-3009.
11. Pradel E., Pagès J.-M. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46:2002;2640-2643.
12. Lewis K. In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol. 3:2001;247-254.
13. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395.
14. Fehlbaum P., Bulet P., Chernysh S., Briand J.-P., Roussel J.-P., Letellier L., Hetru C., Hoffmann J.A. Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc. Natl. Acad. Sci. USA. 93:1996;1221-1225.
15. Mandard N., Sodano P., Labbe H., Bonmatin J.-M., Bulet P., Hetru C., Ptak M., Vovelle F. Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimentional nuclear magnetic resonance data. Eur. J. Biochem. 256:1998;404-410.
16. Chevalier J., Pagès J.-M., Eyraud A., Malléa M. Modification of membrane permeability involved in antibiotic resistance in Klebsiella pneumoniae. Biochem. Biophys. Res. Commun. 274:2000;496-499.
17. Dé E., Baslé A., Jaquinod M., Saint N., Malléa M., Molle G., Pagès J.-M. A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol. Microbiol. 41:2001;189-198.
18. Plesiat P., Nikaido H. Outer membrane of Gram-negative bacteria are permeable to steroid probes. Mol. Microbiol. 6:1992;1323-1333.
19. Hancock R.E.W., Chapple D. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1999;1317-1323.
20. Huang H.W. Action of antimicrobial peptides: two-state model. Biochemistry. 36:2000;8347-8352.
21. Guo L., Lim K.B., Poduje C.M., Daniel M., Gunn J.S., Hackett M., Miller S.I. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell. 95:1998;189-198.
22. Chevalier J., Malléa M., Pagès J.-M. Comparative aspects of norfloxacin, cefepime and spermine diffusion through the F porin channel of Enterobacter cloacae. Biochem. J. 348:2000;223-227.
23. Hagman K.E., Lucas C.E., Balthazar J.T., Snyder L., Nilles M., Judd R.C., Shafer W.M. The MtrD protein of Neisseria gonorrhoeae is a member of the resistance/nodulation/division protein family constituting part of an efflux system. Microbiology. 143:1997;2117-2125.
24. Shafer W.M., Qu X.-D., Waring A.J., Lehrer R.I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA. 95:1998;1829-1833.
25. Daugelavicios R., Bakiene E., Bamford D.H. Stages of polymyxin B interaction with the Escherichia coli cell envelope. Antimicrob. Agents Chemother. 44:2000;2969-2978.